Levalbuterol; pharmacologic properties and use in the treatment of pediatric and adult asthma
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 90 (6) , 583-592
- https://doi.org/10.1016/s1081-1206(10)61859-5
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- ReplyJournal of Allergy and Clinical Immunology, 2002
- Inverse Correlation between (S)-Albuterol Levels and FEV1 in the Emergency DepartmentAcademic Emergency Medicine, 2002
- The effect of the distomer, (S)-albuterol, is not through alteration of the pharmacokinetics of (R)-albuterol: A population PK analysisJournal of Allergy and Clinical Immunology, 2002
- Impact of decreasing doses of racemic albuterol and levalbuterol on efficacy: A pooled analysisJournal of Allergy and Clinical Immunology, 2002
- Levalbuterol and racemic albuterol: Are there therapeutic differences?Journal of Allergy and Clinical Immunology, 2001
- The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patientsJournal of Allergy and Clinical Immunology, 2001
- 858 Cytokine, chemokine, and nitric oxide (NO) release in stimulated small airway epithelial cells (SAEC) treated with ?2-agonist enantiomers of albuterolJournal of Allergy and Clinical Immunology, 2000
- Pharmacokinetics of (R, S)-Albuterol after Aerosol Inhalation in Healthy Adult VolunteersJournal of Pharmaceutical Sciences, 1998
- Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cellsBritish Journal of Clinical Pharmacology, 1996
- Pediatric asthma deaths in Victoria: The mild are at riskPediatric Pulmonology, 1992